| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/12/1999 | EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 05/12/1999 | EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 05/12/1999 | EP0759942A4 Interleukin-15 receptors |
| 05/12/1999 | EP0739354B1 Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0527752B1 Expression of bordetella pertactin antigens in pichia |
| 05/12/1999 | EP0481000B1 Receptors for fibroblast growth factors |
| 05/12/1999 | DE19840875A1 Tumor-suppressing protein conductin |
| 05/12/1999 | CN1216584A Immunity to trypanosomatids species |
| 05/12/1999 | CN1216582A Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases |
| 05/12/1999 | CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 05/12/1999 | CN1216550A Anti-microbial protein |
| 05/12/1999 | CN1216549A Antipathogenic peptides and compositions comprising them |
| 05/12/1999 | CN1043350C Method for preparation of cardiac muscle cell growth stimulus peptide |
| 05/11/1999 | US5902877 Adsorbent of interleukins, process for removing the same, and adsorber for the same |
| 05/11/1999 | US5902799 Methods of modulating tissue growth and regeneration |
| 05/11/1999 | US5902787 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 05/11/1999 | US5902785 Cartilage induction by bone morphogenetic proteins |
| 05/11/1999 | US5902735 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for hirudin, hirudin obtained, and its pharmaceutical use |
| 05/11/1999 | US5902723 Selectively removing a nucleotide by cleavage at terminal ends with catalytic antibodies; identifying excision site and repeating process; for concurrent parallel sequence analysis |
| 05/11/1999 | US5902588 Water soluble nonantigenic polymer with a secondary or tertiary amine, spacer moiety and covalent linkage to a nucleophile consisting of proteins and chemotherapeutic agents; improved bioactivity, pi and ph optimum |
| 05/11/1999 | US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902582 Use of TFPI inhibitor for treatment of cancer |
| 05/11/1999 | CA2210262C Method for collecting hemolymph of insects |
| 05/11/1999 | CA2141871C Novel attenuated pseudomonas aeruginosa strains |
| 05/11/1999 | CA2127362C Expression and purification of recombinant soluble tissue factor |
| 05/11/1999 | CA2124085C Receptor for oncostatin m and leukemia inhibitory factor |
| 05/11/1999 | CA2122724C Fusion proteins comprising mgf and il-3 |
| 05/11/1999 | CA2074162C Composition to improve survival of biological materials |
| 05/11/1999 | CA2061177C Bacteriocin from lactococcus lactis subspecies lactis |
| 05/11/1999 | CA2014264C Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
| 05/11/1999 | CA1340538C Recombinant coccidiosis vaccines |
| 05/11/1999 | CA1340534C Production of immunoproximity catalysts |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999022028A1 Modulators of actin |
| 05/06/1999 | WO1999022027A1 Reagents and methods useful for detecting diseases of the breast |
| 05/06/1999 | WO1999022010A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
| 05/06/1999 | WO1999022008A1 Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody |
| 05/06/1999 | WO1999022003A1 Binary viral expression system in plants |
| 05/06/1999 | WO1999022002A1 A novel mitogenic cyclin and uses thereof |
| 05/06/1999 | WO1999022001A1 Method for regulating the differentiation/proliferation of hematopoietic stem cells |
| 05/06/1999 | WO1999022000A1 Inhibitor protein of the wnt signal pathway |
| 05/06/1999 | WO1999021999A2 Wnt-1 inducible genes |
| 05/06/1999 | WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | WO1999021997A1 Viral encoded semaphorin protein receptor dna and polypeptides |
| 05/06/1999 | WO1999021996A1 Methods and compositions for the diagnosis and treatment of cataracts |
| 05/06/1999 | WO1999021995A1 Treatment and prevention of neurodegenerative diseases using modulators of the interaction of app and a polypeptide defining a pi domain |
| 05/06/1999 | WO1999021994A2 Human vesicle membrane protein-like proteins |
| 05/06/1999 | WO1999021993A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses |
| 05/06/1999 | WO1999021992A2 Nucleic acid molecules encoding a glutamate receptor |
| 05/06/1999 | WO1999021991A1 Bmzf12: a zinc finger gene cloned from bone marrow |
| 05/06/1999 | WO1999021990A1 Cbmaad07: a voltage dependent anion channel protein |
| 05/06/1999 | WO1999021989A1 Human cofactor-a gene cbfblg07 |
| 05/06/1999 | WO1999021988A1 THE HUMAN VESICLE TRAFFICKING PROTEIN SEC22b GENE OF CBFBBA01 |
| 05/06/1999 | WO1999021987A1 Human synaptic glycoprotein sc2 homolog gene cbcbhg02 (alternative spliced short form) |
| 05/06/1999 | WO1999021986A1 Cbfbga09: a human sl15 homolog |
| 05/06/1999 | WO1999021985A1 Cbfbtb01: a human tif4e-like translation initiation factor |
| 05/06/1999 | WO1999021984A1 A human e25 homolog |
| 05/06/1999 | WO1999021983A1 Human atrophin-1 related gene |
| 05/06/1999 | WO1999021982A1 Human m6b1 gene |
| 05/06/1999 | WO1999021981A1 Dna encoding a human proton-gated ion channel and uses thereof |
| 05/06/1999 | WO1999021980A1 P-40/annexin i and related proteins and their role in multidrug resistance |
| 05/06/1999 | WO1999021978A1 Non-transgenic animal model of alzheimer's disease |
| 05/06/1999 | WO1999021976A2 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 05/06/1999 | WO1999021970A1 Insect immunoprotection and a pesticide |
| 05/06/1999 | WO1999021966A1 Erythropoietin-mediated neurogenesis |
| 05/06/1999 | WO1999021965A2 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto |
| 05/06/1999 | WO1999021959A2 Helicobacter pylori vaccine formulations |
| 05/06/1999 | WO1999021891A1 Invertebrate octopamine receptor |
| 05/06/1999 | WO1999021890A1 New nucleotide sequences |
| 05/06/1999 | WO1999021889A1 Purification of molecules |
| 05/06/1999 | WO1999021888A1 Aggregates of human insulin derivatives |
| 05/06/1999 | WO1999021887A2 Method for the production of human blood cytokines |
| 05/06/1999 | WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 05/06/1999 | WO1999021885A1 A human abc transporter-7 (habc7) gene |
| 05/06/1999 | WO1999021884A1 Cblaeh07: a g protein gamma-5 subunit |
| 05/06/1999 | WO1999021883A1 A nematode dopamine transporter, and its sequence |
| 05/06/1999 | WO1999021882A1 Hbv binding polypeptide |
| 05/06/1999 | WO1999021881A1 Methods, kits and compositions pertaining to linear beacons |
| 05/06/1999 | WO1999021878A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | WO1999021875A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 05/06/1999 | WO1999021590A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | WO1999021578A1 Insoluble insulin compositions |
| 05/06/1999 | WO1999021577A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 05/06/1999 | WO1999021576A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | WO1999021575A1 Chemokine alpha-6 |
| 05/06/1999 | WO1999021573A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | WO1999021572A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | WO1999021571A1 Melanocortin receptor ligands and methods of using same |
| 05/06/1999 | WO1999015683A8 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 05/06/1999 | WO1999014341A3 Proteases from gram-positive organisms |
| 05/06/1999 | WO1999013083A3 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 05/06/1999 | WO1999013068A3 Transgenic animal model of prostate cancer |
| 05/06/1999 | WO1999012963A3 Cysteine rich receptors: trail |
| 05/06/1999 | WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 05/06/1999 | WO1999009164A9 Coding sequence haplotypes of the human brca2 gene |
| 05/06/1999 | WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides |
| 05/06/1999 | WO1999007207A9 Hypersensitive response elicitor from pseudomonas syringae and its use |
| 05/06/1999 | WO1998058958A9 Human jagged polypeptide, encoding nucleic acids and methods of use |